Medical Weight Loss Programs

GLP-1 programs typically run $199–$499/month including medication, provider visits, and labs. Branded Wegovy or Zepbound can run higher unless covered by insurance.

Yes. All GLP-1 medications (semaglutide, tirzepatide) require a prescription from a licensed clinician — telehealth visits are standard.

Most patients lose 1–2% of body weight per month on a properly titrated GLP-1 program, with appetite suppression noticeable within the first 1–2 weeks.

Most medical weight-loss programs accept BMI ≥ 27 with a comorbidity (hypertension, prediabetes, sleep apnea) or BMI ≥ 30 without one.

Online programs are typically cheaper and more convenient, but provider continuity and meal-plan customization vary. In-person clinics may offer body-composition scans and on-site exercise programming.

Compounded semaglutide programs average $149–$299/month all-in. Tirzepatide compounded programs typically run $299–$499/month. Branded Wegovy and Zepbound run higher unless covered by insurance.

The active ingredients are FDA approved; compounded formulations are not separately FDA approved. They are dispensed by state-licensed 503A or federally-registered 503B pharmacies regulated by the FDA.

Most patients see appetite suppression within the first 1–2 weeks and 1–2% body-weight reduction per month once titrated to therapeutic dose (typically week 8–12).

Most patients regain weight after stopping unless they continue lifestyle changes, sometimes paired with a maintenance dose. The best clinics include a transition plan in their program.

Generally yes, but oral medications may be absorbed more slowly. Always disclose your full medication list during intake — your clinician will adjust timing where needed.

Yes. Telehealth visits, lab work, and most medically necessary prescriptions are HSA and FSA eligible. Save your receipts and your annual care summary.